{"title":"FTC, DOJ issue statements on clinical integration.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Messenger-model IPAs have a roadmap they can follow to determine whether they are sufficiently clinically integrated to avoid antitrust problems when they collectively negotiate non-risk contracts for participating physicians. Here's how.</p>","PeriodicalId":79817,"journal":{"name":"Capitation management report","volume":"11 1","pages":"5-6"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Capitation management report","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Messenger-model IPAs have a roadmap they can follow to determine whether they are sufficiently clinically integrated to avoid antitrust problems when they collectively negotiate non-risk contracts for participating physicians. Here's how.